Volume 6, Issue 2 (6-2024)                   sjmshm 2024, 6(2): 1-6 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Haghshenas L, Zakari S, Ajami A, Tovakoli N, Ghoodjani E. Comprehensive overview of Postural Tachycardia Syndrome (POTS) in patients with SARS-COV-2 virus, prevalence, causes and treatment. sjmshm 2024; 6 (2) :1-6
URL: http://sjmshm.srpub.org/article-3-207-en.html
Department of Clinical Bioinformatics, Postdoctoral Association, Harvard Medical School, Boston, US.
Abstract:   (162 Views)
The disease of Covid-19 (Covid-19), which is caused by the SARS-CoV-2 virus, can include symptoms or abnormal clinical parameters and medical consequences that last from two or more weeks to months after the initial recovery, which is the so-called Long- COVID or long-term Covid .Although such a change is most often reported in survivors of severe and critical illness, lasting effects also occur in people with mild infections who do not require hospitalization .Postural tachycardia syndrome (POTS), a persistent tachycardia with a persistent increase in heart rate without marked hypotension, has been increasingly reported in patients with SARS-CoV-2. In this study, symptoms, prevalence rate, mechanisms of occurrence and treatment management of the disease have been investigated with a review approach on published studies.

Full-Text [PDF 300 kb]   (33 Downloads)    
Type of Study: Research | Subject: Cardiology and Cardiovascular Medicine
Received: 2024/04/15 | Revised: 2024/06/10 | Accepted: 2024/06/13 | Published: 2024/06/15

1. y Galán JTG: Stroke as a complication and prognostic factor of COVID-19. Neurología (English Edition) 2020, 35(5):318-322. [DOI:10.1016/j.nrleng.2020.04.013] [PMCID]
2. Paybast S, Gorji R, Mavandadi S: Guillain-Barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature. The neurologist 2020, 25. [DOI:10.1097/NRL.0000000000000291] [PMID] [PMCID]
3. Hanafi R, Roger P-A, Perin B, Kuchcinski G, Deleval N, Dallery F, Michel D, Hacein-Bey L, Pruvo J-P, Outteryck O: COVID-19 neurologic complication with CNS vasculitis-like pattern. American Journal of Neuroradiology 2020, 41(8):1384-1387. [DOI:10.3174/ajnr.A6651] [PMID] [PMCID]
4. Chadda KR, Blakey EE, Huang CL-H, Jeevaratnam K: Long COVID-19 and Postural Orthostatic Tachycardia Syndrome-Is Dysautonomia to Be Blamed? Frontiers in Cardiovascular Medicine 2022, 9. [DOI:10.3389/fcvm.2022.860198] [PMID] [PMCID]
5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama 2020, 323(11):1061-1069. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
6. Pranata R, Huang I, Raharjo SB: Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Indian pacing and electrophysiology journal 2020, 20(5):193-198. [DOI:10.1016/j.ipej.2020.08.001] [PMID] [PMCID]
7. Hassani M, Fathi Jouzdani A, Motarjem S, Ranjbar A, Khansari N: How COVID‐19 can cause autonomic dysfunctions and postural orthostatic syndrome? A Review of mechanisms and evidence. Neurology and Clinical Neuroscience 2021, 9(6):434-442. [DOI:10.1111/ncn3.12548] [PMID] [PMCID]
8. Robertson D: The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci 1999, 317:75-77. [DOI:10.1097/00000441-199902000-00001] [PMID]
9. Fedorowski A, Li H, Yu X, Koelsch KA, Harris VM, Liles C, Murphy TA, Quadri SM, Scofield RH, Sutton R: Antiadrenergic autoimmunity in postural tachycardia syndrome. Ep Europace 2017, 19(7):1211-1219. [DOI:10.1093/europace/euw154] [PMID] [PMCID]
10. Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, Low PA, Lennon VA, Shen W-K: Postural orthostatic tachycardia syndrome: the Mayo clinic experience. In: Mayo Clinic Proceedings: 2007. Elsevier: 308-313. [DOI:10.4065/82.3.308] [PMID]
11. Raj SR: The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Indian pacing and electrophysiology journal 2006, 6(2):84.
12. Amekran Y, Damoun N, El Hangouche AJ: Postural orthostatic tachycardia syndrome and post-acute COVID-19. Global Cardiology Science and Practice 2022, 2022(1-2). [DOI:10.21542/gcsp.2022.13] [PMID] [PMCID]
13. Arnold AC, Ng J, Raj SR: Postural tachycardia syndrome-diagnosis, physiology, and prognosis. Autonomic Neuroscience 2018, 215:3-11. [DOI:10.1016/j.autneu.2018.02.005] [PMID] [PMCID]
14. Bhatia R, Kizilbash SJ, Ahrens SP, Killian JM, Kimmes SA, Knoebel EE, Muppa P, Weaver AL, Fischer PR: Outcomes of adolescent-onset postural orthostatic tachycardia syndrome. The Journal of pediatrics 2016, 173:149-153. [DOI:10.1016/j.jpeds.2016.02.035] [PMID]
15. Blitshteyn S, Whitelaw S: Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunologic research 2021, 69(2):205-211 [DOI:10.1007/s12026-021-09185-5] [PMID] [PMCID]
16. Eslami M, Mollazadeh R, Mirshafiee S, Sehat P, Alizadeh F, Emkanjoo Z, Far VL, Shahmohamadi E: Postural orthostatic tachycardia syndrome and orthostatic hypotension post COVID-19. Infectious Disorders Drug Targets 2022.
17. Goldstein DS: The possible association between COVID-19 and postural tachycardia syndrome. Heart rhythm 2021, 18(4):508-509. [DOI:10.1016/j.hrthm.2020.12.007] [PMID] [PMCID]
18. Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vallée A: Clinical characterization of dysautonomia in long COVID-19 patients. Scientific reports 2021, 11(1):1-7. [DOI:10.1038/s41598-021-93546-5] [PMID] [PMCID]
19. Fu Q, VanGundy TB, Galbreath MM, Shibata S, Jain M, Hastings JL, Bhella PS, Levine BD: Cardiac origins of the postural orthostatic tachycardia syndrome. Journal of the American College of Cardiology 2010, 55(25):2858-2868. [DOI:10.1016/j.jacc.2010.02.043] [PMID] [PMCID]
20. Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD: Postural orthostatic tachycardia syndrome: JACC focus seminar. Journal of the American College of Cardiology 2019, 73(10):1207-1228 [DOI:10.1016/j.jacc.2018.11.059] [PMID]
21. Schondorf R, Low PA: Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993, 43(1 Part 1):132-132. [DOI:10.1212/WNL.43.1_Part_1.132] [PMID]
22. Rysz S, Al-Saadi J, Sjöström A, Farm M, Campoccia Jalde F, Plattén M, Eriksson H, Klein M, Vargas-Paris R, Nyrén S: COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nature communications. 2021, 12(1):1-12. [DOI:10.1038/s41467-021-22713-z] [PMID] [PMCID]
23. Szabó GT, Kiss A, Csanádi Z, Czuriga D: Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019. ESC Heart Failure. 2021, 8(1):171. [DOI:10.1002/ehf2.13078] [PMID] [PMCID]
24. Baig AM, Khaleeq A, Ali U, Syeda H: Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS chemical neuroscience 2020, 11(7):995-998. [DOI:10.1021/acschemneuro.0c00122] [PMID]
25. Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S, Raoult D: 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? European journal of nuclear medicine and molecular imaging 2021, 48(2):592-595. [DOI:10.1007/s00259-020-04973-x] [PMID] [PMCID]
26. Swai J, Hu Z, Zhao X, Rugambwa T, Ming G: Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovascular Disorders 2019, 19(1):1-12. [DOI:10.1186/s12872-019-01298-y] [PMID] [PMCID]
27. Williams DP, Koenig J, Carnevali L, Sgoifo A, Jarczok MN, Sternberg EM, Thayer JF: Heart rate variability and inflammation: a meta-analysis of human studies. Brain, behavior, and immunity 2019, 80:219-226. [DOI:10.1016/j.bbi.2019.03.009] [PMID]
28. Blitshteyn S: Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus 2015, 24(13):1364-1369. [DOI:10.1177/0961203315587566] [PMID]
29. Wu J, Tang Y: Revisiting the immune balance theory: a neurological insight into the epidemic of COVID-19 and its alike. Frontiers in Neurology 2020, 11:566680. [DOI:10.3389/fneur.2020.566680] [PMID] [PMCID]
30. Shiravi AA, Ardekani A, Sheikhbahaei E, Heshmat-Ghahdarijani K: Cardiovascular complications of SARS-CoV-2 vaccines: an overview. Cardiology and Therapy 2021:1-9. [DOI:10.1007/s40119-021-00248-0] [PMID] [PMCID]
31. Hermel M, Sweeney M, Abud E, Luskin K, Criado JP, Bonakdar R, Gray J, Ahern T: COVID-19 Vaccination Might Induce Postural Orthostatic Tachycardia Syndrome: A Case Report. Vaccines 2022, 10(7):991. [DOI:10.3390/vaccines10070991] [PMID] [PMCID]
32. Eldokla AM, Numan MT: Postural orthostatic tachycardia syndrome after mRNA COVID-19 vaccine. Clinical Autonomic Research 2022, 32(4):307-311. [DOI:10.1007/s10286-022-00880-3] [PMID] [PMCID]
33. Li H, Yu X, Liles C, Khan M, Vanderlinde‐Wood M, Galloway A, Zillner C, Benbrook A, Reim S, Collier D: Autoimmune basis for postural tachycardia syndrome. Journal of the American Heart Association 2014, 3(1):e000755. [DOI:10.1161/JAHA.113.000755] [PMID] [PMCID]
34. Sandroni P, Low PA: Other autonomic neuropathies associated with ganglionic antibody. Autonomic Neuroscience 2009, 146(1-2):13-17. [DOI:10.1016/j.autneu.2008.10.022] [PMID] [PMCID]
35. Raj SR, Fedorowski A, Sheldon RS: Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ 2022, 194(10):E378-E385. [DOI:10.1503/cmaj.211373] [PMID] [PMCID]
36. Raj SR, Guzman JC, Harvey P, Richer L, Schondorf R, Seifer C, Thibodeau-Jarry N, Sheldon RS: Canadian cardiovascular society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Canadian Journal of Cardiology 2020, 36(3):357-372. [DOI:10.1016/j.cjca.2019.12.024] [PMID]
37. Kavi L, Gammage MD, Grubb BP, Karabin BL: Postural tachycardia syndrome: multiple symptoms, but easily missed. In., vol. 62: British Journal of General Practice; 2012: 286-287. [DOI:10.3399/bjgp12X648963] [PMID] [PMCID]
38. O'Sullivan JS, Lyne A, Vaughan CJ: COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Reports CP 2021, 14(6):e243585. [DOI:10.1136/bcr-2021-243585] [PMID] [PMCID]
39. Sheldon RS, Grubb BP, Olshansky B, Shen W-K, Calkins H, Brignole M, Raj SR, Krahn AD, Morillo CA, Stewart JM: 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart rhythm 2015, 12(6):e41-e63. [DOI:10.1016/j.hrthm.2015.03.029] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.